These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32860850)

  • 41. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway.
    Gao L; Chen M; Ouyang Y; Li R; Zhang X; Gao X; Lin S; Wang X
    Life Sci; 2018 Jun; 202():188-194. PubMed ID: 29625193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
    Koren Carmi Y; Khamaisi H; Adawi R; Noyman E; Gopas J; Mahajna J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors.
    Marti P; Stein C; Blumer T; Abraham Y; Dill MT; Pikiolek M; Orsini V; Jurisic G; Megel P; Makowska Z; Agarinis C; Tornillo L; Bouwmeester T; Ruffner H; Bauer A; Parker CN; Schmelzle T; Terracciano LM; Heim MH; Tchorz JS
    Hepatology; 2015 Nov; 62(5):1497-510. PubMed ID: 26173433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications.
    Herrmann E; Bögemann M; Bierer S; Eltze E; Hertle L; Wülfing C
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):73-81. PubMed ID: 16375646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Natali PG; Bagnato A
    Can J Physiol Pharmacol; 2010 Jun; 88(6):676-81. PubMed ID: 20628434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of endothelin A receptor in colon cancer metastasis: in vitro and in vivo evidence.
    Nie S; Zhou J; Bai F; Jiang B; Chen J; Zhou J
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E85-91. PubMed ID: 23818293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion.
    Khamaisi H; Mahmoud H; Mahajna J
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
    Matassa DS; Amoroso MR; Lu H; Avolio R; Arzeni D; Procaccini C; Faicchia D; Maddalena F; Simeon V; Agliarulo I; Zanini E; Mazzoccoli C; Recchi C; Stronach E; Marone G; Gabra H; Matarese G; Landriscina M; Esposito F
    Cell Death Differ; 2016 Sep; 23(9):1542-54. PubMed ID: 27206315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    J Biol Chem; 2003 Oct; 278(42):41294-301. PubMed ID: 12907686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
    Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy.
    Xiao S; Li Y; Pan Q; Ye M; He S; Tian Q; Xue M
    J Cell Biochem; 2019 Mar; 120(3):2940-2953. PubMed ID: 30537410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer.
    Feng L; Shen F; Zhou J; Li Y; Jiang R; Chen Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32190895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
    Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.
    Vaiou M; Pangou E; Liakos P; Sakellaridis N; Vassilopoulos G; Dimas K; Papandreou C
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2141-58. PubMed ID: 27530445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.